(Q51168180)

31 March 2018

title

Intravail: highly effective intranasal delivery of peptide and protein drugs. (English)

1 reference

31 March 2018

author name string

Edward T Maggio

series ordinal

1

1 reference

31 March 2018

language of work or name

English

0 references

publication date

1 July 2006

1 reference

31 March 2018

Expert Opinion on Drug Delivery

published in

1 reference

31 March 2018

volume

3

1 reference

31 March 2018

issue

4

1 reference

31 March 2018

page(s)

529-539

1 reference

31 March 2018

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.529

Gut hormone PYY(3-36) physiologically inhibits food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.529

[D-LEU-4]-OB3, a synthetic leptin agonist, improves hyperglycemic control in C57BL/6J ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.529

Enhanced bioavailability of calcitonin formulated with alkylglycosides following nasal and ocular administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.529

Correlation of tetradecylmaltoside induced increases in nasal peptide drug delivery with morphological changes in nasal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.529

Transport of drugs from the nasal cavity to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.529

Bi-directional nasal delivery of aerosols can prevent lung deposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.529

The nasal mucociliary clearance: relevance to nasal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.529

Effect of environmental contaminants on nasal lysozyme secretions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.529

Drug metabolism in the nasal cavity: relevance to toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.529

Respiratory tract uptake of inhalants and metabolism of xenobiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.529

Metabolic capacity of nasal tissue interspecies comparisons of xenobiotic-metabolizing enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.529

Glutathione transferases in human nasal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.529

Age- and gender-related trends in the expression of glutathione S-transferases in human nasal mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.529

Drug metabolism in the nasal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.529

The biopharmaceutical aspects of nasal mucoadhesive drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.529

Pharmaceutical applications of mucoadhesion for the non-oral routes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.529

Effects of the permeability enhancers, tetradecylmaltoside and dimethyl-beta-cyclodextrin, on insulin movement across human bronchial epithelial cells (16HBE14o-).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.529

Tetradecylmaltoside (TDM) enhances in vitro and in vivo intestinal absorption of enoxaparin, a low molecular weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.529

Nasal administration of low molecular weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.529

Safety review of benzalkonium chloride used as a preservative in intranasal solutions: an overview of conflicting data and opinions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.529

21 January 2018

Identifiers

DOI

10.1517/17425247.3.4.529

1 reference

31 March 2018

1 reference

31 March 2018